Billionaires Invest Heavily in Brain-Computer Interfaces
- Elon Musk’s Neuralink has implanted devices in five patients as of September 2025.
- Neuralink raised $650 million in Series E funding, making it a leader in the BCI field.
- Sam Altman-backed Merge Labs aims to raise $250 million with a potential valuation of $850 million.
Billionaires like Elon Musk and Sam Altman are investing heavily in brain-computer interfaces (BCIs), viewing them as strategic control points for future technology platforms. Despite significant funding, experts caution that BCIs are far from achieving “thought reading” capabilities, and billionaire ambitions may overshadow their therapeutic potential.
The involvement of billionaires brings visibility and capital to the BCI industry but also risks centralizing power over this critical technology. (Source)
